NCT05171049 2026-02-23
ASTER
Anthos Therapeutics, Inc.
Phase 3 Terminated
Anthos Therapeutics, Inc.
Anthos Therapeutics, Inc.
LEO Pharma
Alexion Pharmaceuticals, Inc.
Janssen Research & Development, LLC
Daiichi Sankyo
Sanofi
Rovi Pharmaceuticals Laboratories
Sanofi